Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells

Chao-Hung Lee, C. D. Bolinger, M. S. Bartlett, R. B. Kohler, C. E. Wilde, J. W. Smith

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

It has been difficult to obtain pure Pneumocystis carinii antigen either from cultures or from infected lungs for use in producing a specific antibody against P. carinii. This report describes an approach toward producing a monoclonal antibody that bypasses the antigen purification steps. P. carinii infection was developed in Sprague-Dawley rats by the method of immunosuppression with cortisone. The infected lungs were homogenized, and the homogenate was used to immunize Sprague-Dawley rats. Rat spleen cells were then fused with SP2/0 mouse myeloma cells. Hybridoma clones were screened for antibody production against P. carinii by immunoperoxidase staining techniques and by enzyme-linked immunosorbent assay, using as antigens homogenates of normal rat lung, homogenates of P. carinii-infected rat lung, and harvests of P. carinii grown with WI-38 cells. Out of six hybridoma clones obtained that produced antibodies against P. carinii, one was able to produce ascitic fluid. This monoclonal antibody reacted with two P. carinii antigens with masses of about 35,000 and 65,000 daltons in P. carinii-infected lungs and three proteins with masses of about 35,000, 65,000, and 110,000 daltons in P. carinii that was harvested from a WI-38 cell culture.

Original languageEnglish
Pages (from-to)505-508
Number of pages4
JournalJournal of Clinical Microbiology
Volume23
Issue number3
StatePublished - 1986

Fingerprint

Pneumocystis carinii
Spleen
Monoclonal Antibodies
Lung
Antigens
Hybridomas
Sprague Dawley Rats
Clone Cells
Pneumocystis Infections
Antibodies
Ascitic Fluid
Cortisone
Immunoenzyme Techniques
Immunosuppression
Antibody Formation
Cell Culture Techniques
Enzyme-Linked Immunosorbent Assay
Staining and Labeling

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Lee, C-H., Bolinger, C. D., Bartlett, M. S., Kohler, R. B., Wilde, C. E., & Smith, J. W. (1986). Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells. Journal of Clinical Microbiology, 23(3), 505-508.

Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells. / Lee, Chao-Hung; Bolinger, C. D.; Bartlett, M. S.; Kohler, R. B.; Wilde, C. E.; Smith, J. W.

In: Journal of Clinical Microbiology, Vol. 23, No. 3, 1986, p. 505-508.

Research output: Contribution to journalArticle

Lee, C-H, Bolinger, CD, Bartlett, MS, Kohler, RB, Wilde, CE & Smith, JW 1986, 'Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells', Journal of Clinical Microbiology, vol. 23, no. 3, pp. 505-508.
Lee, Chao-Hung ; Bolinger, C. D. ; Bartlett, M. S. ; Kohler, R. B. ; Wilde, C. E. ; Smith, J. W. / Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells. In: Journal of Clinical Microbiology. 1986 ; Vol. 23, No. 3. pp. 505-508.
@article{84894065f763442a918381173267c38c,
title = "Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells",
abstract = "It has been difficult to obtain pure Pneumocystis carinii antigen either from cultures or from infected lungs for use in producing a specific antibody against P. carinii. This report describes an approach toward producing a monoclonal antibody that bypasses the antigen purification steps. P. carinii infection was developed in Sprague-Dawley rats by the method of immunosuppression with cortisone. The infected lungs were homogenized, and the homogenate was used to immunize Sprague-Dawley rats. Rat spleen cells were then fused with SP2/0 mouse myeloma cells. Hybridoma clones were screened for antibody production against P. carinii by immunoperoxidase staining techniques and by enzyme-linked immunosorbent assay, using as antigens homogenates of normal rat lung, homogenates of P. carinii-infected rat lung, and harvests of P. carinii grown with WI-38 cells. Out of six hybridoma clones obtained that produced antibodies against P. carinii, one was able to produce ascitic fluid. This monoclonal antibody reacted with two P. carinii antigens with masses of about 35,000 and 65,000 daltons in P. carinii-infected lungs and three proteins with masses of about 35,000, 65,000, and 110,000 daltons in P. carinii that was harvested from a WI-38 cell culture.",
author = "Chao-Hung Lee and Bolinger, {C. D.} and Bartlett, {M. S.} and Kohler, {R. B.} and Wilde, {C. E.} and Smith, {J. W.}",
year = "1986",
language = "English",
volume = "23",
pages = "505--508",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells

AU - Lee, Chao-Hung

AU - Bolinger, C. D.

AU - Bartlett, M. S.

AU - Kohler, R. B.

AU - Wilde, C. E.

AU - Smith, J. W.

PY - 1986

Y1 - 1986

N2 - It has been difficult to obtain pure Pneumocystis carinii antigen either from cultures or from infected lungs for use in producing a specific antibody against P. carinii. This report describes an approach toward producing a monoclonal antibody that bypasses the antigen purification steps. P. carinii infection was developed in Sprague-Dawley rats by the method of immunosuppression with cortisone. The infected lungs were homogenized, and the homogenate was used to immunize Sprague-Dawley rats. Rat spleen cells were then fused with SP2/0 mouse myeloma cells. Hybridoma clones were screened for antibody production against P. carinii by immunoperoxidase staining techniques and by enzyme-linked immunosorbent assay, using as antigens homogenates of normal rat lung, homogenates of P. carinii-infected rat lung, and harvests of P. carinii grown with WI-38 cells. Out of six hybridoma clones obtained that produced antibodies against P. carinii, one was able to produce ascitic fluid. This monoclonal antibody reacted with two P. carinii antigens with masses of about 35,000 and 65,000 daltons in P. carinii-infected lungs and three proteins with masses of about 35,000, 65,000, and 110,000 daltons in P. carinii that was harvested from a WI-38 cell culture.

AB - It has been difficult to obtain pure Pneumocystis carinii antigen either from cultures or from infected lungs for use in producing a specific antibody against P. carinii. This report describes an approach toward producing a monoclonal antibody that bypasses the antigen purification steps. P. carinii infection was developed in Sprague-Dawley rats by the method of immunosuppression with cortisone. The infected lungs were homogenized, and the homogenate was used to immunize Sprague-Dawley rats. Rat spleen cells were then fused with SP2/0 mouse myeloma cells. Hybridoma clones were screened for antibody production against P. carinii by immunoperoxidase staining techniques and by enzyme-linked immunosorbent assay, using as antigens homogenates of normal rat lung, homogenates of P. carinii-infected rat lung, and harvests of P. carinii grown with WI-38 cells. Out of six hybridoma clones obtained that produced antibodies against P. carinii, one was able to produce ascitic fluid. This monoclonal antibody reacted with two P. carinii antigens with masses of about 35,000 and 65,000 daltons in P. carinii-infected lungs and three proteins with masses of about 35,000, 65,000, and 110,000 daltons in P. carinii that was harvested from a WI-38 cell culture.

UR - http://www.scopus.com/inward/record.url?scp=0022628827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022628827&partnerID=8YFLogxK

M3 - Article

C2 - 3514660

AN - SCOPUS:0022628827

VL - 23

SP - 505

EP - 508

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 3

ER -